Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

被引:2
|
作者
Blimark, Cecilie Hveding [1 ,2 ]
Carlson, Kristina [3 ]
Day, Christopher [1 ]
Einarsdottir, Sigrun [1 ]
Juliusson, Gunnar [4 ]
Karma, Moshtak [5 ]
Knut-Bojanowska, Dorota [6 ]
Larfors, Gunnar [7 ]
Turesson, Ingemar [8 ]
Scivetti, Mariana Villegas [1 ]
Sverrisdottir, Ingigerdur [1 ,9 ]
机构
[1] Sahlgrens Univ Hosp, Dept Haematol & Coagulat, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Med & Clin Nutr, Gothenburg, Sweden
[3] Univ Hosp Uppsala, Uppsala, Sweden
[4] Lund Univ & Hosp, Lund Stem Cell Ctr, Lund, Sweden
[5] Sodra Alvsborg Hosp, Dept Haematol, Boras, Sweden
[6] Uddevalla Cent Hosp, Dept Haematol, Uddevalla, Sweden
[7] Uppsala Univ, Dept Med Sci, Unit Haematol, Uppsala, Sweden
[8] Skane Univ Hosp, Malmo, Sweden
[9] Univ Iceland, Fac Med, Reykjavik, Iceland
关键词
D O I
10.1182/blood-2023-174228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Development of a "myeloma risk score" using a population-based registry on paraproteinemia and myeloma
    Ong, F
    Hermans, J
    Noordijk, EM
    De Kieviet, W
    Seelen, PJ
    Wijermans, PW
    Kluin-Nelemans, JC
    LEUKEMIA & LYMPHOMA, 1997, 27 (5-6) : 495 - 501
  • [22] The initial management of multiple myeloma in the era of novel agents: 2021 and beyond
    Nadeem, Omar
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (02) : 213 - 215
  • [23] Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry
    Walinder, Goran
    Samuelsson, Jan
    Nasman, Per
    Hansson, Markus
    Juliusson, Gunnar
    Forsberg, Karin
    Svensson, Ronald
    Linder, Olle
    Carlson, Kristina
    Kristinsson, Sigurdur Y.
    Mellqvist, Ulf Henrik
    Blimark, Cecilie Hveding
    Turesson, Ingemar
    Nahi, Hareth
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (05) : 376 - 382
  • [24] Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry
    Redder, Louise
    Klausen, Tobias W.
    Vangsted, Annette Juul
    Gregersen, Henrik
    Andersen, Niels F.
    Pedersen, Robert S.
    Szabo, Agoston G.
    Frederiksen, Mikael
    Frolund, Ulf C.
    Helleberg, Carsten
    Nielsen, Lene Kongsgaard
    Pedersen, Per T.
    Salomo, Morten
    Gimsing, Peter
    Frederiksen, Henrik
    Abildgaard, Niels
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 119 - 124
  • [25] The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study from the Japanese Society of Myeloma
    Kawamura, Koji
    Tsukada, Nobuhiro
    Kanda, Yoshinobu
    Ikeda, Takashi
    Yoshida, Akiyo
    Ueda, Yasunori
    Ishida, Tadao
    Suzuki, Kenshi
    Murakami, Hirokazu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (07) : 1392 - 1398
  • [26] Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study
    Langseth, Oystein O.
    Myklebust, Tor A.
    Johannesen, Tom B.
    Hjertner, Oyvind
    Waage, Anders
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 108 (06) : 486 - 492
  • [27] Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study
    Oortgiesen, Berdien
    van Roon, Eric N.
    Joosten, Peter
    Kibbelaar, Robby
    Storm, Huib
    Hovenga, Sjoerd
    Van Rees, Bas P.
    Woolthuis, Gerhard
    Veeger, Nic J. G. M.
    Hoogendoorn, Mels
    BLOOD, 2014, 124 (21)
  • [28] Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study
    Thorsteinsdottir, Sigrun
    Dickman, Paul W.
    Landgren, Ola
    Blimark, Cecilie
    Hultcrantz, Malin
    Turesson, Ingemar
    Bjorkholm, Magnus
    Kristinsson, Sigurdur Y.
    HAEMATOLOGICA, 2018, 103 (09) : E412 - E415
  • [29] Fractures and survival in multiple myeloma: results from a population-based study
    Thorsteinsdottir, Sigrun
    Gislason, Gauti
    Aspelund, Thor
    Sverrisdottir, Ingigerdur
    Landgren, Ola
    Turesson, Ingemar
    Bjorkholm, Magnus
    Kristinsson, Sigurdur Y.
    HAEMATOLOGICA, 2020, 105 (04) : 1067 - 1073
  • [30] Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
    Nucci, Marcio
    Anaissie, Elias
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1211 - 1225